Cefuroxime Sodium

头孢呋辛钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCefuroxime Sodium
Drug Alias NameCefuroxima Sodium头孢呋新钠头拖呋辛钠Cefuroximum SodiumZinacef
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsMeningitis +[14] 
Global Approved IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsMeningitis +[10] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryN/A
Original Approved Date1977/01/01
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTeligent
China Registration ClassN/A

Develop Information

Active CompaniesTeligentHikma PharmaceuticalsUniversity Of Leeds +[4] 
Inactive CompaniesB Braun MedicalPai Holdings LLC
Active IndicationsAcute bacterial skin and skin structure infectionsMeningitisRectal Diseases +[11] 
Inactive IndicationsLower Respiratory Tract InfectionsSurgical Wound InfectionBacteremia

Other Information

ATC CodeJ01DC02S01AA27
Related LinksWikipediaDrugBankKEGG